Nvidia's $6-trillion milestone looms. Here's when options traders see it happening
Source: CNBC
Nvidia rose 1.3% Friday to a record, lifting its market value to just under $5.7 trillion and helping the Nasdaq-100 close at a new high; Nvidia represents 13% of the Nasdaq-100 and 8% of the S&P 500. Options pricing implies about a 50% chance the company reaches $6 trillion by month-end and a 67% chance by Dec. 18, while traders show call skew. An Nvidia buyback announcement was described by Highline Asset Management’s Ben Emons as a signal of confidence in long-run AI demand; options deltas also imply comparable odds of moves in the opposite direction.
Analysis
The key signal is positioning, not proof of a new earnings inflection. A valuation milestone can become self-reinforcing if options hedging and benchmark flows amplify a breakout, but delta-derived probabilities are not independent forecasts—and a similarly sized move down remains possible. Call skew suggests upside protection is relatively sought after; it can support near-term momentum while making fresh call exposure less attractive on a risk-adjusted basis.
For days to weeks, NVDA’s index weight makes it a concentrated driver of Nasdaq-100 returns: a reversal could pressure QQQ even if broader participation holds up. Over 1–3 months, the test is whether company guidance and observable AI infrastructure spending validate the rally; the buyback is a confidence signal, not evidence by itself of incremental demand or per-share value creation. Over 6–18 months, the central risk is that capital spending by AI customers fails to translate into durable returns, weakening demand expectations and the multiple. Conversely, sustained spending and supply availability could extend the leadership trade.
Contrarian point: the market is treating a round-number valuation as a catalyst when it is an outcome of price and share count. Do not chase solely on the odds of crossing it. Verify buyback scale and execution, customer spending trends, and the next guidance updates. The bullish thesis weakens on a failed breakout followed by lower earnings expectations; it strengthens if guidance and spending indicators rise together.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
Key Decisions for Investors
- Avoid adding outright NVDA exposure solely on the milestone probabilities. For portfolios already concentrated in mega-cap growth, consider a defined-risk QQQ put spread as a 1–2 month hedge; size it to the portfolio’s actual NVDA/tech exposure and review after the next company guidance update.
- If seeking upside participation, use a 1–2 month NVDA call spread rather than outright calls, and only if the live option chain shows acceptable implied volatility and a bounded debit. Call skew makes uncapped premium buying less compelling; do not infer attractive pricing from the article’s probabilities.
- Treat buyback commentary as a watch item until the company discloses the authorization’s scale, pace, and execution. Reassess the bullish case against guidance and customer spending indicators rather than the share-price milestone.
- Falsification: a sustained failure to hold the breakout, paired with weaker forward guidance or evidence of slowing AI infrastructure spending, would argue against the momentum thesis and favor reducing exposure or retaining the hedge. A breakout supported by stronger guidance and spending evidence would argue against pressing a short.
More News
- Satya Nadella reinvented Microsoft once. Can he do it again in the AI era?
- Cerebras stock climbs 6% after Sam Altman calls the chipmaker a 'close partner'
- While OpenAI and Anthropic battle over data privacy, more companies look to open models and ‘sovereign AI’
- Mizuho reiterates Cerebras Systems stock rating on inference growth
- Here are 3 things we're watching in the stock market in the week ahead
- Wall St futures dip as tech stocks take a breather